INJ Price Prediction: $4.92 Is the Next Stop — Why You Should Sell the Bounce

Injective (INJ) has experienced a sharp 8% decline in a single session, leaving traders searching for a bottom that hasn't arrived. The technical intelligence is clear: with a flat MACD and aggressive sell-side flow overwhelming all existing bids, the momentum is heavily skewed to the downside, pointing toward a potential drop to the $4.92 level.

Market dynamics currently favor short sellers, as the lack of credible buying response suggests that any minor price recovery is likely a trap. Until a definitive reversal pattern emerges to counter the overwhelming sell pressure, the most prudent strategy is to sell the bounce rather than attempting to catch a falling knife in the INJ market.

INJ just dropped 8% in a single session and the tape shows no credible buying response. With the MACD dead flat, shorts dominating market positioning, and aggressive sell-side flow overwhelming bids, the technical outlook remains bearish. The current price prediction suggests that $4.92 is the next logical stop. For traders looking to navigate this volatility, the directive is clear: sell the bounce until proven otherwise.